Medi Assist Healthcare Services vs New India Assurance business model compares third-party claims administration and processing services for insurers against PSU general insurance underwriting across multiple product categories to see which health insurance ecosystem has better business model.

New India Assurance vs ICICI Lombard growth compares PSU direct general insurance underwriting across multiple product categories against private diversified general insurance underwriting with digital distribution to see which general insurance has better growth.

Nifty Pharma index falls close to 2 percent today with Gland Pharma, Piramal Pharma and Aurobindo Pharma leading declines. Check the full list of top losers here.

Honasa Consumer vs Godrej Consumer Products business model compares direct-to-consumer beauty brand portfolio built around Mamaearth against household and personal care diversification with international operations to see which personal care fmcg has better business model.

Mahanagar Gas vs Indraprastha Gas business model compares concentrated Mumbai metropolitan city gas distribution with dense network against concentrated Delhi NCR city gas distribution with dense network to see which city gas distribution has better business model.

Sai Life Sciences vs Laurus Labs business model compares concentrated CDMO services for global innovator pharmaceutical companies against diversified pharmaceutical manufacturing spanning API, generics and CDMO services to see which pharma cdmo has better business model.

Supreme Petrochem vs Chemplast Sanmar business model compares concentrated polystyrene and styrenic polymer manufacturing against chlor-alkali chemicals and specialty PVC resin manufacturing to see which petrochemicals has better business model.

Akums Drugs and Pharmaceuticals vs Suven Pharmaceuticals (Cohance) growth compares concentrated domestic contract manufacturing for branded generics against concentrated specialty pharma intermediate and CDMO manufacturing to see which pharma manufacturing has better growth.

Morarka Finance Q1 results FY27: net profit jumps 171.9% to Rs 0.38 crore as revenue nearly doubles, though absolute figures remain modest for the microcap NBFC. Shares up 4.12% as of 22 July 2026.